Skip to main content

Table 1 Baseline characteristics of the 90 study participants

From: Hepatic steatosis, detected by hepatorenal index in ultrasonography, as a predictor of insulin resistance in obese subjects

 

Inclusion groups

Centre of Obesity

Sixth Tromsø Study

N

Median (SD)

Range

N

Median (SD)

Range

Age, years

22

43.0 (12.76)

21–69

68

66.0 (10.84)

32–82

Height, cm

22

167.5 (6.87)

156–179

68

166.0 (9.08)

141–189

Weight, kg

22

113.0 (16.13)

83.5–148.0

68

81.3 (15.51)

50.6–123.5

Systolic BP, mmHg

22

126.0 (11.36)

112–159

68

137.0 (22.07)

96–213

Diastolic BP, mmHg

22

74.0 (8.16)

62–94

68

78.0 (8.42)

50–102

BMI, kg/m2

22

41.8 (5.66)

31.8–52.7

68

28.0 (5.35)

19.3–45.6

HOMA1-IR

22

2.5 (1.75)

0.8–6.5

65

0.8 (3.18)

0.2–25.5

WBISI

22

0.3 (0.77)

0.03–2.9

0

-

-

AST, U/L

22

18.0 (9.32)

12.0–53.0

66

29.5 (1.23)

14.0–71.0

ALT, U/L

4

38.5 (6.70)

29.0–45.0

66

39.0 (20.36)

14.0–102.0

γ-GT, U/L

21

29.0 (45.72)

13.0–198.0

65

82.0 (82.74)

14.0–398.0

ALP, U/L

4

88.0 (9.22)

80.0–99.0

66

81.0 (38.96)

36.0–322.0

  1. SD Standard Deviation, BP Blood Pressure, BMI Body Mass Index, HOMA1-IR Homeostasis Model Assessment of Insulin Resistance 1, WBISI Whole Body Insulin Sensitivity Index, AST Aspartate Aminotransferase, ALT Alanine Aminotransferase, γ-GT Gamma-Glutamyl Transferase, ALP Alkaline Phosphatase